A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells
Amineh Ghaderi(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Georgios Z. Rassidakis(Karolinska University Hospital), Ali Moshfegh(Karolinska University Hospital), Ηλίας Δράκος(University of Crete), Anders Österborg(Karolinska University Hospital), Parviz Kokhaei(Arak University of Medical Sciences), Jemina Lehto(Kancera (Sweden)), Luigi De Petris(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Mohammad Ali Okhovat(Karolinska University Hospital), Wen Zhong(Karolinska University Hospital), Johan Schultz(Kancera (Sweden)), Ehsan Manouchehri Doulabi(Science for Life Laboratory), Thomas Olin(Kancera (Sweden))
Cited by 15
Related Papers
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453